发明名称 |
Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity |
摘要 |
Described herein are variant, recombinant β-glucocerebrosidase proteins characterized as having increased stability relative to recombinant wild-type β-glucocerebrosidase. Also provided herein are variant, recombinant β-glucocerebrosidase proteins characterized as retaining more catalytic activity relative to recombinant wild-type β-glucocerebrosidase. Further described herein are variant, recombinant β-glucocerebrosidase proteins that can have amino acid variations at one or more of the following positions: 316, 317, 321 and 145. Methods of making the variant, recombinant β-glucocerebrosidase proteins are also described as well as methods of treating patients having lysosomal storage diseases. |
申请公布号 |
US9566316(B2) |
申请公布日期 |
2017.02.14 |
申请号 |
US201614987204 |
申请日期 |
2016.01.04 |
申请人 |
AMICUS THERAPEUTICS, INC. |
发明人 |
Do Hung V. |
分类号 |
C07K1/00;C12N9/24;A61K38/00;A61K38/47;A61K31/445 |
主分类号 |
C07K1/00 |
代理机构 |
Servilla Whitney LLC |
代理人 |
Servilla Whitney LLC |
主权项 |
1. A composition comprising:
a variant, recombinant human β-glucocerebrosidase protein, wherein the protein has at least one substitution relative to SEQ ID NO: 1, and wherein the substitution is selected from the group consisting of
F316A relative to SEQ ID NO: 21,L317F relative to SEQ ID NO: 21,K321V relative to SEQ ID NO: 21,K321A relative to SEQ ID NO: 21,H145L relative to SEQ ID NO: 17,H145F relative to SEQ ID NO: 17,and combinations thereof; and isofagomine. |
地址 |
Cranbury NJ US |